Trademark Overview
On Tuesday, May 19, 2026, a trademark application was filed for XUANMU with the United States Patent and Trademark Office. The USPTO has given the XUANMU trademark a serial number of 99831322. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 19, 2026. This trademark is owned by Hangzhou Xuanmu Pharmaceutical Co., Ltd.. The XUANMU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of invasive aspergillosis and invasive mucormycosis in adult patients; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Antifungal preparations; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of hyperlipidemia; Antimicrobial preparations for treating invasive aspergillosis and invasive mucormycosis in adult patients; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of invasive aspergillosis and invasive mucormycosis in adult patients; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of tho...
